Aptose Biosciences Alpha and Beta Analysis
| APTODelisted Stock | USD 2.01 0.91 82.73% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aptose Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aptose Biosciences over a specified time horizon. Remember, high Aptose Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aptose Biosciences' market risk premium analysis include:
Beta (5.10) | Alpha (1.08) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aptose |
Aptose Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aptose Biosciences market risk premium is the additional return an investor will receive from holding Aptose Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aptose Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aptose Biosciences' performance over market.| α | -1.08 | β | -5.1 |
Aptose Biosciences Fundamentals Vs Peers
Comparing Aptose Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aptose Biosciences' direct or indirect competition across all of the common fundamentals between Aptose Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aptose Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aptose Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aptose Biosciences to competition |
| Fundamentals | Aptose Biosciences | Peer Average |
| Return On Equity | -6.94 | -0.31 |
| Return On Asset | -1.42 | -0.14 |
| Current Valuation | 9.69 M | 16.62 B |
| Shares Outstanding | 2.55 M | 571.82 M |
| Shares Owned By Insiders | 24.80 % | 10.09 % |
| Shares Owned By Institutions | 11.51 % | 39.21 % |
| Number Of Shares Shorted | 53.15 K | 4.71 M |
Aptose Biosciences Opportunities
Aptose Biosciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Aptoses Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly ... | 02/12/2025 |
2 | Aptose Biosciences Earns Hold Rating from Analysts at StockNews.com | 02/28/2025 |
3 | Aptose Biosciences Inc expected to post a loss of 10.50 a share - Earnings Preview - TradingView | 03/21/2025 |
4 | Aptose Biosciences Inc. Sees Significant Decline in Short Interest | 03/28/2025 |
5 | Why Aptose Biosciences Stock Is Down Over 40 | 04/01/2025 |
About Aptose Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aptose or other delisted stocks. Alpha measures the amount that position in Aptose Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Aptose Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Aptose Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aptose Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aptose Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aptose Biosciences. Please utilize our Beneish M Score to check the likelihood of Aptose Biosciences' management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Aptose Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |